Delivery Order SPE2DB20D1100-SPE2DB25FE6P8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,871.12 to AmerisourceBergen Drug Corp for Pantoprazole Sodium Delayed-Release 40 mg tablets (90-count supply). This competitively awarded, non-set-aside contract carries a firm fixed price and represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA. The work is to be completed by August 21, 2025, with performance occurring at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Pantoprazole Sodium Delayed-Release 40 mg tablets in a quantity of 1,000 units, with a ceiling value of $2,058.66. This competitive award, which utilizes firm fixed price pricing, represents a non-set-aside contract and is scheduled for completion by August 29, 2025. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,072.98 for 1,000 tablets of Pantoprazole Sodium delayed-release 40 mg on September 8, 2025, with completion scheduled for September 9, 2025. This non-set-aside contract utilizes firm fixed-price pricing and is being performed at the company's corporate headquarters in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a 90-count package. This order, valued at $1,120.33, represents a firm fixed-price delivery against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026. The award is non-set-aside and was...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,841.28, is for the supply of 4,562,828,860 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The contract has a period of performance through November 16, 2023. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,187,922 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The firm fixed-price contract, valued at $2,008.44, has an ultimate completion date of October 24, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen, a for-profit organization, is the prime contractor with no major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a ceiling value of $1,129.71. This contract represents a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and was awarded without set-aside provisions through open competition. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a contract value of $1,013.16. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively awarded. The order is set for ultimate completion on August 1, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken,...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Pantoprazole Sodium Delayed-Release 40 mg tablets. The $24,742.17 firm-fixed price contract has a performance period through February 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,038.98 Firm Fixed Price Delivery Order is for the supply of 4,563,401,913 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets. The contract has an ultimate completion date of January 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE6P8Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,015.70 to AmerisourceBergen Drug Corp for 1,000 tablets of Pantoprazole Sodium delayed-release 40 mg, with a completion date of September 15, 2025. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award based on the contractor's demonstrated capability to meet federal pharmaceutical procurement requirements. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves critical federal medical supply needs across the Department of Defense and other government healthcare systems through this comprehensive global pharmaceutical support vehicle. The company's extensive federal contract portfolio demonstrates its versatility in supplying a broad spectrum of pharmaceutical products, including specialty medications, generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support military and veteran healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 9/12/25 |